Detalhe da pesquisa
1.
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.
J Med Genet
; 59(12): 1196-1205, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162852
2.
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.
J Med Genet
; 59(7): 632-643, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844974
3.
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Genet Med
; 24(1): 119-129, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906479
4.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med
; 22(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665703
5.
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Hum Mutat
; 40(11): e1-e23, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209999
6.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213659
7.
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study.
J Med Genet
; 55(8): 546-554, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730597
8.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat
; 39(5): 593-620, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446198
9.
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Genet Med
; 24(10): 2208, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205748
10.
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
medRxiv
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496424
11.
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.
J Clin Oncol
; 41(5): 1092-1104, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493335
12.
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
NPJ Breast Cancer
; 9(1): 37, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173335
13.
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
J Natl Cancer Inst
; 114(1): 109-122, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320204
14.
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
J Clin Oncol
; 40(14): 1529-1541, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077220
15.
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Nat Commun
; 12(1): 2986, 2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990587
16.
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Nat Commun
; 12(1): 1078, 2021 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597508
17.
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
NPJ Breast Cancer
; 6: 44, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964118
18.
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
JAMA Oncol
; 6(8): 1218-1230, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614418
19.
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
J Natl Cancer Inst
; 112(12): 1242-1250, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107557
20.
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
J Clin Oncol
; 38(7): 674-685, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841383